Pro Medicus Limited
PME
Kedudukan dalam Saham
#1603
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Harga Saham
$129.26
Modal Pasaran
$13.50B
Perubahan (1 hari)
-0.21%
Perubahan (1 tahun)
-30.86%
Negara
AU
Perdagangan Pro Medicus Limited (PME)
Kategori
Healthcare
Nisbah P/E bagi Pro Medicus Limited (PME)
Nisbah P/E pada October 2026 TTM: 64.40
Menurut laporan kewangan dan harga saham terkini Pro Medicus Limited, nisbah P/E semasa (TTM) ialah 64.40. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 171.13.
Sejarah nisbah P/E bagi Pro Medicus Limited dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 64.40 | -75.09% |
| 2025 | 258.50 | 51.06% |
| 2024 | 171.13 | 51.44% |
| 2023 | 113.00 | 13.95% |
| 2022 | 99.17 | -49.98% |
| 2021 | 198.27 | 66.43% |
| 2020 | 119.13 | -13.39% |
| 2019 | 137.56 | 65.63% |
| 2018 | 83.05 | 41.98% |
| 2017 | 58.49 | -22.48% |
| 2016 | 75.46 | 12.61% |
| 2015 | 67.01 | 14.60% |
| 2014 | 58.47 | 627.67% |
| 2013 | 8.04 | -52.16% |
| 2012 | 16.79 | -51.86% |
| 2011 | 34.89 | 199.74% |
| 2010 | 11.64 | -4.40% |
| 2009 | 12.18 | -16.24% |
| 2008 | 14.54 | -24.08% |
| 2007 | 19.15 | -13.27% |
| 2006 | 22.08 | 25.02% |
| 2005 | 17.66 | 3.55% |
| 2004 | 17.05 | -7.71% |
| 2003 | 18.48 | 3.39% |
| 2002 | 17.87 | -23.13% |
| 2001 | 23.25 | -33.46% |
| 2000 | 34.94 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 19.68 | -69.45% |
US
|
|
| 44.30 | -31.21% |
US
|
|
| -47.78 | -174.18% |
US
|
|
| -123.90 | -292.38% |
US
|
|
| - | - |
US
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.